Clinical Trials Directory

Trials / Sponsors / Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Academic / Other · 9 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5F
Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Phase 22025-06-18
RecruitingTwo-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squam
Head and Neck Squamous Cell Carcinoma
Phase 1 / Phase 22023-11-08
Active Not RecruitingSpanish Study for Molecular Characterization of Thyroid Carcinoma
Differentiated Thyroid Carcinoma, Medullary Thyroid Carcinoma
—2021-06-14
CompletedCetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.
Squamous Cell Carcinoma of the Head and Neck
—2020-12-18
CompletedStudy to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Phase 22020-06-03
CompletedStudy of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck
Head and Neck Cancer
Phase 22011-03-09
TerminatedPaclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Che
Head and Neck Cancer
Phase 22011-02-16
CompletedTPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer
Head and Neck Cancer
Phase 22008-10-01
CompletedTPF Plus Cisplatin and Radiotherapy vs TPF Plus Cetuximab and Radiotherapy to Treat Head and Neck Cancer.
Head and Neck Cancer
Phase 32008-07-07